- Home
- GDTC vs PCLA Comparison
GDTC vs PCLA Comparison
Compare GDTC & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- PCLA
- Stock Information
- Founded
- GDTC 2018
- PCLA 2008
- Country
- GDTC Singapore
- PCLA Japan
- Employees
- GDTC N/A
- PCLA N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- PCLA Building Products
- Sector
- GDTC Health Care
- PCLA Consumer Discretionary
- Exchange
- GDTC Nasdaq
- PCLA Nasdaq
- Market Cap
- GDTC 28.0M
- PCLA 32.3M
- IPO Year
- GDTC 2023
- PCLA 2025
- Fundamental
- Price
- GDTC $2.27
- PCLA $1.50
- Analyst Decision
- GDTC Buy
- PCLA
- Analyst Count
- GDTC 1
- PCLA 0
- Target Price
- GDTC $5.00
- PCLA N/A
- AVG Volume (30 Days)
- GDTC 6.5K
- PCLA 1.8M
- Earning Date
- GDTC 01-01-0001
- PCLA 01-01-0001
- Dividend Yield
- GDTC N/A
- PCLA N/A
- EPS Growth
- GDTC N/A
- PCLA N/A
- EPS
- GDTC N/A
- PCLA N/A
- Revenue
- GDTC $368,838.00
- PCLA $5,475,228.00
- Revenue This Year
- GDTC $5.37
- PCLA N/A
- Revenue Next Year
- GDTC N/A
- PCLA N/A
- P/E Ratio
- GDTC N/A
- PCLA N/A
- Revenue Growth
- GDTC N/A
- PCLA 40.19
- 52 Week Low
- GDTC $1.20
- PCLA $0.37
- 52 Week High
- GDTC $4.05
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- GDTC 54.58
- PCLA N/A
- Support Level
- GDTC $2.25
- PCLA N/A
- Resistance Level
- GDTC $2.35
- PCLA N/A
- Average True Range (ATR)
- GDTC 0.08
- PCLA 0.00
- MACD
- GDTC 0.03
- PCLA 0.00
- Stochastic Oscillator
- GDTC 85.29
- PCLA 0.00
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.